Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013...
Transcript of Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013...
![Page 1: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/1.jpg)
1
FCDS Educational Webcast SeriesFebruary 28, 2013
Steven Peace, BS, CTRSusan Smith Pierce, CTR
Gema Midence, MBA, CTR
Genitourinary NeoplasmsUpdated for 2012 Requirements and CSv02.04
![Page 2: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/2.jpg)
Presentation Outline
2
General Information and Anatomy Kidney – Renal Parenchyma Kidney – Renal Pelvis Ureters Bladder Prostate
Multiple Primary and Histology Coding Rules (MPH)
Collaborative Stage Data Collection System (CSv02.04)
FCDS Required Site Specific Factors (SSFs)
NCCN Treatment Guidelines
Text Documentation
![Page 3: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/3.jpg)
Genitourinary System
3Source: http://medicaltrue.com/urinary-tract
![Page 4: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/4.jpg)
Genitourinary System
4 Source: http://cancervic.org.au/bladder_cancer
![Page 5: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/5.jpg)
Kidney
5
![Page 6: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/6.jpg)
U.S. Incidence/Mortality
6 Source: American Cancer Society Cancer Facts and Figures 2012
New Cases1,638,910 all sites
64,770 kidney & renal pelvis
Deaths577,190 all sites13,157 kidney & renal pelvis
![Page 7: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/7.jpg)
Risk Factors/Screening
7
Risk Factors Cigarette Smoking First-degree relative Long-term PCB exposure Long-term use of
medicines Obesity
Screening None CT Scan Ultrasound Incidental Finding
![Page 8: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/8.jpg)
Kidney - Anatomy
8 Source: http://foxriverwatch.com/kidney_cancer
![Page 9: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/9.jpg)
Kidney - Anatomy
9 Source: 2007 Multiple Primary and Histology Coding Rules
![Page 10: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/10.jpg)
Kidney - Anatomy
10
1. Parenchyma2. Cortex3. Medulla4. Perirenal fat5. Capsule6. Ureter7. Pelvis of kidney8. Renal vessels9. Hilum10. Calyx
Source: http://training.seer.cancer.gov
![Page 11: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/11.jpg)
Kidney - Anatomy
11
Figure I-2-13. Structures Adjacent to Kidney
Source: Collaborative Stage Data Collection System, Part I, Section 2
![Page 12: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/12.jpg)
Kidney - Histology
12
Renal Cell Carcinoma and Renal Cell Carcinoma Subtypes
8312 Renal cell carcinoma is a GROUP term for glandular(adeno) carcinoma of the kidney
8255 Adenocarcinoma with mixed subtypes** 8260 Papillary (Chromophil)* 8310 Clear Cell 8316 Cyst associated, cystic 8317 Chromophobe* 8318 Sarcomatoid (Spindle cell) 8319 Collecting duct type (Bellini duct) 8320 Granular cell 8510 Medullary carcinoma, NOS; medullary adenocarcinoma 8959 Malignant cystic nephroma
Source: 2007 Multiple Primary & Histology Coding Rules
![Page 13: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/13.jpg)
Kidney - MPH Rules
13
Kidney MPH Includes:o Kidney Parenchymao Renal Parenchyma
(C649)
![Page 14: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/14.jpg)
14
![Page 15: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/15.jpg)
15
![Page 16: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/16.jpg)
16
![Page 17: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/17.jpg)
17
![Page 18: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/18.jpg)
18 Etcetera through rules…
![Page 19: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/19.jpg)
19
![Page 20: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/20.jpg)
20
![Page 21: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/21.jpg)
Kidney MPH Rules - Example 1
21
Patient has two tumors in upper pole of left kidney. Both are T1a neoplasms (small tumor size)
Histology 1: RCC, NOS (8312/3) Histology 2: RCC papillary type (8260/3)
One Primary or Two Primaries ? One Primary per Rule M9 RCC, NOS and an RCC Subtype in two tumors
Histologic Type/Code ? 8260/3 – Rule H12 - code the specific type
![Page 22: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/22.jpg)
Kidney MPH Rules - Example 2
22
Patient has two tumors in upper pole of left kidney. Both are T1a neoplasms (small tumor size)
Histology 1: RCC papillary type (8260/3) Histology 2: RCC tubulocystic type (8316/3)
One Primary or Two Primaries ? Two Primaries per Rule M10 Two different subtypes of RCC – not RCC and a subtype
Histologic Type/Histology Code ? 8260/3 – RCC papillary type 8316/3 – RCC cystic type
![Page 23: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/23.jpg)
Kidney MPH Rules - Example 3
23
Patient has one tumor in upper pole of right kidney.
Histology: RCC with papillary and cystic features
One Primary or Two Primaries ? One Primary = One Tumor
Histologic Type/Histology Code ? 8255/3 – adenocarcinoma with mixed subtypes Per Rule H6
![Page 24: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/24.jpg)
Kidney – Collaborative Stage
24
V02.04
![Page 25: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/25.jpg)
25
Version v.02.04
KidneyParenchyma
![Page 26: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/26.jpg)
26
![Page 27: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/27.jpg)
27
Code Description
![Page 28: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/28.jpg)
28
![Page 29: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/29.jpg)
29
CS Extension
![Page 30: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/30.jpg)
CS Lymph Nodes
30 Source: AJCC Cancer Staging Atlas
![Page 31: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/31.jpg)
CS Mets at Dx
31
![Page 32: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/32.jpg)
CS Site-Specific Factors
32
SSF1: Invasion Beyond Capsule
SSF2: Vein Involvement
SSF3: Ipsilateral Adrenal Gland Involvement
SSF4: Sarcomatoid Features
SSF5: Histologic Tumor Necrosis
SSF6: Fuhrman Nuclear Grade
SSF7: Size of Metastasis in Lymph Nodes
SSF8: Extranodal Extension
Not Required
Not Required
![Page 33: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/33.jpg)
Kidney Cancers - Treatment
33
![Page 34: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/34.jpg)
34
![Page 35: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/35.jpg)
Kidney – Early Stage
35
![Page 36: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/36.jpg)
Kidney – Early Stage
36
![Page 37: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/37.jpg)
Kidney – Late Stage
37
![Page 38: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/38.jpg)
Kidney – Late Stage
38
![Page 39: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/39.jpg)
Kidney – Late Stage
39
![Page 40: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/40.jpg)
40
Urothelial Neoplasms
![Page 41: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/41.jpg)
41
Urothelium
The layer of transitional epithelium that lines the wall of the renal pelvis, ureters, the bladder, and
parts of the urethra
The lining is made up of transitional epithelial cells that stop urine from entering the body.
Urine consists of water and waste products.
![Page 42: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/42.jpg)
42
Field Effect Theory
The field effect theory suggests that the urothelium has undergone a widespread change, perhaps in
response to a carcinogen, making it more sensitive to malignant transformations.
As a result, multiple tumors arise more easily.
![Page 43: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/43.jpg)
43
Implantation Theory
The implantation theory suggests that tumor cells in one location lose their attachments and float in
the urine until they attach (implant) on another site.
Urothelial tumors commonly spread in a head-to-toe direction, for example from the renal pelvis to
the ureter(s) to the bladder.
![Page 44: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/44.jpg)
U.S. Incidence/Mortality
44 Source: American Cancer Society Cancer Facts and Figures 2012
New Cases1,638,910 all sites
73,510 bladder
Deaths577,190 all sites14,880 bladder
![Page 45: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/45.jpg)
Risk Factors/Screening
45
Risk Factors Cigarette Smoking Chemical Exposures:
dyes, solvents, paints, rubber, benzene, etc.
Cyclophosphamide Chronic Inflammation Parasite Schistosoma
Screening None Blood in Urine Ultrasound Cystoscopy Incidental Finding
![Page 46: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/46.jpg)
Anatomy
46Source: http://www.medicinenet.com
![Page 47: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/47.jpg)
Anatomy
47
![Page 48: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/48.jpg)
Anatomy
48
![Page 49: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/49.jpg)
Anatomy
49
![Page 50: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/50.jpg)
50
Urothelium Mucosa Epithelium Transitional Epithelium Mucosal Surface Transitional Mucosa Tunica Mucosa Vesicae Urinariae
Lamina Propria Submucosa Suburothelial Connective
Tissue SubepithelialTissue Stroma Muscularis Mucosa Transitinoal Epithelium
Anatomy
Muscularis Propria Submucosa Muscularis Externa Smooth Muscle
![Page 51: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/51.jpg)
Histology
51
Urothelial Carcinoma = Transitional Cell Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Small Cell Carcinoma
Small Cell Neuroendocrine
Source: http://iws.collin.edu/mweis/A&P
![Page 52: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/52.jpg)
Histology
52Source Multiple Primary & Histology Coding Rules - Table 1 – Urothelial Tumors
![Page 53: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/53.jpg)
Histology
53Source Multiple Primary & Histology Coding Rules - Table 1 – Urothelial Tumors
![Page 54: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/54.jpg)
Tumor Grade
54 Source: http://pathguy.com/lectures/bladder.htm
![Page 55: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/55.jpg)
Tumor Grade
55 Source: nccn.org
![Page 56: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/56.jpg)
Tumor Grade
56 Source: http://sciencedirect.com
![Page 57: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/57.jpg)
Urothelial MPH Rules
57
Urothelial MPH Includes:o Kidney Renal Pelviso Uretero Bladdero Urinary Other(C659, C669, C670-C679, C680-C689)
![Page 58: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/58.jpg)
58
![Page 59: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/59.jpg)
59
![Page 60: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/60.jpg)
60
![Page 61: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/61.jpg)
61
![Page 62: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/62.jpg)
62
![Page 63: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/63.jpg)
Urothelial MPH – Example 1
63
Patient with history of invasive cancer of the bladder diagnosed in 1996 and treated with TURBT and BCG.
Patient seen in 2013 with new non-invasive papillary TCC.
Histology 1: Urothelial Carcinoma – 8120/3
Histology 2: Non-Invasive PTCC of Bladder – 8130/2
One Primary or Two Primaries? One – Rule M6
Histology – 8120/3 – Rule H14 code the invasive histology
![Page 64: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/64.jpg)
Urothelial MPH – Example 2
64
Patient with history of invasive cancer of the bladder in 2001 being seen in 2013 with new tumor in right ureter (TCC).
Histology 1: Urothelial Carcinoma of Bladder – 8120/3 Histology 2: TCC of Ureter – 8120/3
One Primary or Two Primaries? Two Rule M7 – tumors greater than 3 years apart NOTE: Rule M8 includes all urothelial (except C679 only M6)
Seq 01 – dx 2001 – C679 M8120/3 Seq 02 – dx 2013 – C659 M8120/3
![Page 65: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/65.jpg)
Urothelial MPH – Example 3
65
Patient with history of invasive cancer of the bladder in 2011 being seen now with new tumor in right ureter (TCC).
Histology 1: Urothelial Carcinoma of Bladder – 8120/3 Histology 2: TCC of Ureter – 8120/3
One Primary or Two Primaries? One Rule M8 – tumors less than 3 years apart NOTE: Rule M8 includes all urothelial (except neoplasms that
occur only in the bladder C679 – then use Rule M6)
Diagnosis 2011 with Primary Site C679 and Histology 8120/3 Ureter TCC diagnosed less than 3 years after bladder – Rule M8
![Page 66: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/66.jpg)
Bladder– Collaborative Stage
66
V02.04
![Page 67: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/67.jpg)
67
Version v.02.04
Bladder
![Page 68: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/68.jpg)
Bladder Cancer Staging
68Source: http://pathologyoutlines.com/topic/bladderstaging
![Page 69: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/69.jpg)
Bladder Cancer Staging
69Source: http://cancerresearchuk.orgSource: http://onlinehealthcareservi ces.com
![Page 70: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/70.jpg)
70
![Page 71: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/71.jpg)
71
![Page 72: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/72.jpg)
72
![Page 73: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/73.jpg)
73
![Page 74: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/74.jpg)
74
![Page 75: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/75.jpg)
75
![Page 76: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/76.jpg)
76
![Page 77: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/77.jpg)
77
Bladder Site-Specific Factors
SSF1: WHO/ISUP Grade
SSF2: Size of Metastasis in Lymph Node
SSF3: Extranodal Extension
![Page 78: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/78.jpg)
Renal Pelvis– Collaborative Stage
78
V02.04
![Page 79: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/79.jpg)
79
Version v.02.04
Kidney/Renal Pelvis
![Page 80: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/80.jpg)
Urinary, Other – Collaborative Stage
80
V02.04
![Page 81: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/81.jpg)
81
Version v.02.04
Urinary Other
![Page 82: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/82.jpg)
Urothelial Cancers - Treatment
82
![Page 83: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/83.jpg)
83
![Page 84: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/84.jpg)
84
![Page 85: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/85.jpg)
85
![Page 86: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/86.jpg)
86
![Page 87: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/87.jpg)
87
![Page 88: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/88.jpg)
88
![Page 89: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/89.jpg)
89
![Page 90: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/90.jpg)
90
![Page 91: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/91.jpg)
PROSTATE
91
![Page 92: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/92.jpg)
Age-Adjusted Cancer Death Rates, Males by Site, U.S. 1930-2007
92
![Page 93: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/93.jpg)
Incidence / Mortality
93Prostate Cancer 1975-2008
![Page 94: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/94.jpg)
Risk Factors/Screening Most common male cancer 2nd leading cause of cancer death in U.S. men African-American men 2.5 x higher death rate others Estimated new cases: 240,890; deaths: 33,720 Risk Factors:
Age Race/Ethnicity Family history Genetics Diet
Screening DRE PSA
94
![Page 95: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/95.jpg)
Screening Recommendations U.S. Preventive Services Task Force
American Urological Association
American Cancer Society
ASCO/NCCN Guidelines
Individual Urologist
High-Risk Patients95
![Page 96: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/96.jpg)
Anatomy
The prostate is a gland found ONLY in men
It is located in front of the rectum and under the bladder
The size of a healthy prostate gland is about the size of a walnut
Source: http://www.abbottdiagnostics.comU.S. National Cancer Institute
96
![Page 97: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/97.jpg)
Anatomy
Vas Deferens(vasa deferens)
Seminal Vesicle(surface view)
Seminal Vesicle
(cutaway view)
Prostatic urethraApex of prostate
Base of prostate
97
![Page 98: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/98.jpg)
Anatomy
Source: SEER Training Website, www.training.seer.cancer.gov
Lateral lobes
Anterior lobe
Median lobe
Posterior lobe Ejaculatory ducts
Prostate capsule
Urethra
98
![Page 99: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/99.jpg)
Histology 99% Adenocarcinoma Code acinar as adenoca
1% Other Sarcoma Small cell carcinoma Lymphoma
PIN III Do NOT abstract 30% men develop Ca Follow-up for 2 years
Image source: N
ational Cancer Institute
99
![Page 100: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/100.jpg)
Prostate - MPH Rules
100
![Page 101: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/101.jpg)
Prostate - MPH Rules
Only ONE Prostate Cancer DX per patient lifetime
Dx of Acinar Carcinoma, Code to 8140 (Adenocarcinoma)
101
![Page 102: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/102.jpg)
Prostate MPH - Example
Patient seen as outpatient as follow-up to elevated PSA. Patient had multiple biopsies in multiple prostate lobes All specimens were positive for adenocarcinoma
One primary or Multiple? One Single Tumor Multiple Biopsies
Histologic Type? Adenocarcinoma
102
![Page 103: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/103.jpg)
Prostate – Collaborative Stage
103
V02.04
![Page 104: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/104.jpg)
104
Version v.02.04
Prostate
![Page 105: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/105.jpg)
105
![Page 106: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/106.jpg)
Clinical Stage/Pathological Stage
Clinical Extension Pathological Extension
106
CS Ext – Clinical Stage
Prior to Prostatectomy
Clinical Evaluation Only Bx for Elevated PSA Clinically Inapparent Clinically Apparent
Used to Develop a Treatment Plan
SSF3 – Pathological Stage
PROSTATECTOMY
Pathological Evaluation Surgical Findings Prostatectomy Specimen
Code 970 if No Surgery
Surgery is Part of the Treatment Plan
![Page 107: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/107.jpg)
Clinical Stage: Why Important?? Clinical Stages T1a and T1b Incidentally detected during a TURP
Clinical stages T1c and T2 PSA test positive – detects earlier stage
Clinical Stage T3 DRE detects palpable disease sufficient to indicate
that the tumor has penetrated through the prostate capsule
107
![Page 108: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/108.jpg)
Clinical Stage T4 Indicates local invasion of a structure adjacent to
the prostate other than the seminal vesicle(s).
T4a indicates a DRE exam with tumor invading the bladder neck, external sphincter or rectum.
T4b indicates clinical findings of invasion into the levator muscles or a tumor that is fixed to the pelvis.
108
Clinical Stage: Why Important??
![Page 109: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/109.jpg)
Clinical Stage Illustrations
109
T1c
T2 (a,b,c)
T3 (a,b,c)
T4 (a,b)Material provided by Prostate Cancer Research Institute (PCRI)
![Page 110: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/110.jpg)
Pathological Stage Criteria
110
![Page 111: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/111.jpg)
NOT A PROSTECTOMY
111
![Page 112: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/112.jpg)
NOT A PROSTECTOMY
112
When NO PROSTECTOMYCS SSF 3 MUST = 970
![Page 113: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/113.jpg)
Prostatectomy Procedures
113
When PROSTECTOMY IS PERFORMEDCS SSF 3 CANNOT = 970
![Page 114: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/114.jpg)
Pathologic Extension – SSF 3
114
![Page 115: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/115.jpg)
Pathologic Extension – SSF 3
115
![Page 116: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/116.jpg)
Other Prostate Site Specific Factors
116
SSF # SSF Name FCDS Required CoC Required
SSF1 PSA Lab Value YES YES
SSF2 PSA Interpretation - YES
SSF3 CS Extension – Pathologic Ext YES YES
SSF7 Gleason Pattern – biopsy/TURP - YES
SSF8 Gleason Score – biopsy/TURP YES YES
SSF9 Gleason Pattern – prostatecomy/autopsy - YES
SSF10 Gleason Score – prostatectomy/autopsy YES YES
SSF11 Gleason Tertiary – prostatectomy/autopsy - YES
SSF12 Number of Cores Positive - YES
SSF13 Number of Cores Examined - YES
![Page 117: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/117.jpg)
PSA Lab Value – SSF 1
117
![Page 118: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/118.jpg)
118
Gleason Pattern(s) and Score
http://www.stjohnprovidence.org
![Page 119: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/119.jpg)
Gleason Score to Grade Conversion
119
Gleason Score Grade/Differentiation
Gleason 2-6 Well Differentiated
Gleason 7 Moderately Differentiated
Gleason 8-10 Poorly Differentiated
![Page 120: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/120.jpg)
Prostate Cancer - Treatment
120
![Page 121: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/121.jpg)
121
![Page 122: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/122.jpg)
Treatment Options
Observation
Seed RT Surgery
Experimental Hormone
Beam RT
122
![Page 123: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/123.jpg)
123
![Page 124: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/124.jpg)
124
![Page 125: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/125.jpg)
125
![Page 126: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/126.jpg)
126
![Page 127: Updated for 2012 Requirements and CSv02 · 1 FCDS Educational Webcast Series February 28, 2013 Steven Peace, BS, CTR Susan Smith Pierce, CTR Gema Midence, MBA, CTR Genitourinary Neoplasms](https://reader034.fdocuments.in/reader034/viewer/2022050717/5e1487f0d45ece2b7463b957/html5/thumbnails/127.jpg)
Questions
127